Clinical trials are medical research studies that aim to find a better way to manage a particular disease. The purpose of a clinical trial is to evaluate new approaches to learn how people respond to them and what side effects might occur as a result. Clinical trials are considered to be part of best practice medicine and are one of many options for treatment of a disease or illness.
NCARD collaborates with other researchers to perform human clinical trials of immunotherapies, most commonly in thoracic malignancies (mesothelioma and lung cancer). These trials generally run in collaboration with the Department of Medical Oncology and the Department of Respiratory Medicine at Sir Charles Gairdner Hospital. Often, these trials will be run as part of national and international teams. Some trials are also run through Linear Clinical Trials.
Participating in a clinical trial may give you access to new, innovative treatments or may help us understand who will benefit most from those treatments.
People who participate in a clinical trial are often the first to access and benefit from new and emerging treatments. Our Clinical Trials’ team is made up of specialists, doctors, registered nurses and health science professionals.
To find out if a trial is suitable for you, please discuss with your treating medical team first.
